Literature DB >> 30798812

Cardiomyocyte hepcidin: From intracellular iron homeostasis to physiological function.

S Lakhal-Littleton1.   

Abstract

Cellular iron is required for the utilization of oxygen in the cell. Iron in iron-sulfur and heme groups is required for electron transfer and oxygen activation in oxidative phosphorylation, while labile free iron is required for oxygen activation by dioxygenases, and as a catalyst for redox signaling. At the same time, this reactivity with oxygen underpins the production of cell-damaging free radicals in the presence of excess iron. Because the cardiac cell is a major site of oxygen flux, it requires tight control of intracellular iron levels. Until recently, such control was thought to be mediated predominantly by the action of iron regulatory proteins. However, new evidence reveals that cardiomyocyte hepcidin is indispensable for the control of intracellular iron levels, normal metabolism and heart function. This new evidence highlights the need for better understanding of the regulation of cardiomyocyte hepcidin in health and disease.
© 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte; Ferroportin; Heart; Heart failure; Hepcidin; Hypoxia; Inflammation; Iron; Myocardial infarction

Mesh:

Substances:

Year:  2019        PMID: 30798812     DOI: 10.1016/bs.vh.2019.01.009

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  3 in total

Review 1.  In-depth review: is hepcidin a marker for the heart and the kidney?

Authors:  Rengin Elsurer Afsar; Mehmet Kanbay; Avsin Ibis; Baris Afsar
Journal:  Mol Cell Biochem       Date:  2021-05-04       Impact factor: 3.396

Review 2.  Does Hepcidin Tuning Have a Role among Emerging Treatments for Thalassemia?

Authors:  Filomena Longo; Antonio Piga
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

3.  Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.

Authors:  Marc J George; Ola Kleveland; Jorge Garcia-Hernandez; Jutta Palmen; Ruth Lovering; Rune Wiseth; Pål Aukrust; Jorgen Engmann; Jan Kristian Damås; Aroon D Hingorani; Lars Gullestad; Juan P Casas; Thor Ueland
Journal:  J Am Heart Assoc       Date:  2020-06-09       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.